Molnupiravir represents a important development in the battle against COVID-19, functioning as an administered antiviral agent. First designed to combat viruses, its unique mechanism of action – introducing errors into the SARS-CoV-2's genetic code – has demonstrated success in reducing the risk of severe illness and hospitalization in some ind